HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Richard Zigeuner Selected Research
Richard Zigeuner Research Topics
Disease
63
Neoplasms (Cancer)
10/2021 - 09/2003
41
Carcinoma (Carcinomatosis)
05/2023 - 02/2004
37
Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 02/2004
17
Neoplasm Metastasis (Metastasis)
01/2022 - 11/2004
8
Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 04/2011
7
Non-Muscle Invasive Bladder Neoplasms
12/2023 - 12/2016
6
Transitional Cell Carcinoma
04/2011 - 09/2004
5
Urologic Neoplasms (Urological Cancer)
01/2021 - 04/2011
5
Necrosis
01/2019 - 09/2006
5
Kidney Neoplasms (Kidney Cancer)
07/2018 - 02/2004
4
Prostatic Neoplasms (Prostate Cancer)
03/2006 - 11/2003
3
Carcinoma in Situ
01/2021 - 10/2008
3
Thrombosis (Thrombus)
07/2018 - 02/2015
2
Hemorrhage
01/2011 - 12/2009
1
Pain (Aches)
08/2019
1
Postoperative Pain
08/2019
1
Carcinogenesis
12/2017
1
Inflammation (Inflammations)
01/2017
1
Thrombocytosis (Thrombocythemia)
10/2013
1
Circulating Neoplastic Cells
09/2013
1
Chronic Kidney Failure (Chronic Renal Failure)
03/2013
1
Lymphatic Metastasis
10/2011
1
Urinary Fistula
01/2011
1
Ischemia
01/2011
1
Pneumothorax
01/2011
1
Hematuria
01/2010
1
Hemorrhagic Cystitis
01/2010
1
Cystitis
01/2010
1
Hematoma
12/2009
1
Merkel Cell Carcinoma
06/2007
1
Hypoxia (Hypoxemia)
03/2006
1
Disease Progression
11/2004
Drug/Important Bio-Agent (IBA)
8
Biomarkers (Surrogate Marker)
IBA
01/2019 - 12/2004
7
Indicators and Reagents (Reagents)
IBA
11/2017 - 03/2006
4
Antibodies
IBA
01/2019 - 02/2004
4
Proteins (Proteins, Gene)
FDA Link
09/2006 - 09/2004
2
Fibrinogen (Factor I)
FDA Link
05/2023 - 04/2014
2
Hemoglobins (Hemoglobin)
IBA
01/2011 - 09/2003
2
Dihydrotachysterol (AT 10)
IBA
12/2009 - 02/2009
2
Keratin-20 (Cytokeratin 20)
IBA
06/2007 - 02/2004
2
Keratins (Keratin)
IBA
11/2004 - 02/2004
2
Prostate-Specific Antigen (Semenogelase)
IBA
05/2004 - 11/2003
1
Tyrosine Kinase Inhibitors
IBA
01/2022
1
Immune Checkpoint Inhibitors
IBA
01/2022
1
Blood Group Antigens (Blood Groups)
IBA
10/2021
1
ABO Blood-Group System
IBA
10/2021
1
deoxythymidylyl-3'-5'-deoxyadenylate (d(T-A))
IBA
08/2019
1
Analgesics (Analgesic Drugs)
IBA
08/2019
1
Survivin
IBA
01/2019
1
Glycoproteins (Glycoprotein)
IBA
01/2019
1
Creatinine
IBA
07/2018
1
C-Reactive Protein
IBA
01/2017
1
gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)
IBA
07/2015
1
A 7 (A-7)
IBA
05/2015
1
Sunitinib (Sutent)
FDA Link
10/2014
1
Biological Factors
IBA
06/2014
1
Albumins
IBA
06/2014
1
cyclohexane- 1,2,4- tris(methylenesulfonate) (CTMS)
IBA
09/2013
1
DNA (Deoxyribonucleic Acid)
IBA
09/2013
1
Platinum
IBA
10/2011
1
Oxygen (Dioxygen)
IBA
01/2010
1
Adiponectin
IBA
10/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2007
1
Endostatins
IBA
01/2007
1
Mucins
IBA
01/2007
1
fascin
IBA
09/2006
1
alpha-methylacyl-CoA racemase
IBA
03/2006
1
Fatty Acids (Saturated Fatty Acids)
IBA
03/2006
1
Imatinib Mesylate (Gleevec)
FDA Link
02/2005
1
Monophenol Monooxygenase (Tyrosinase)
IBA
02/2005
1
Phosphotransferases (Kinase)
IBA
02/2005
1
Trastuzumab (Herceptin)
FDA Link
01/2005
1
Insulin-Like Growth Factor I (IGF-1)
IBA
12/2004
1
Insulin-Like Peptides
IBA
12/2004
1
IGF Type 1 Receptor (IGF 1 Receptor)
IBA
12/2004
1
Insulin-Like Growth Factor II (Somatomedin A)
IBA
12/2004
1
S-Phase Kinase-Associated Proteins (Skp1 Protein)
IBA
09/2004
1
Ligases (Synthetase)
IBA
09/2004
1
Ubiquitin
IBA
09/2004
Therapy/Procedure
38
Nephroureterectomy
01/2021 - 04/2008
24
Nephrectomy
01/2022 - 04/2007
19
Therapeutics
01/2022 - 09/2004
11
Drug Therapy (Chemotherapy)
01/2021 - 06/2010
8
Lymph Node Excision (Lymph Node Dissection)
01/2019 - 02/2009
6
Thrombectomy
10/2019 - 09/2014
3
Transurethral Resection of Bladder
12/2023 - 01/2020
3
Neoadjuvant Therapy
11/2015 - 04/2011
3
Adjuvant Chemotherapy
02/2013 - 09/2009
2
Cystectomy
01/2021 - 01/2017
2
Length of Stay
07/2018 - 08/2015
1
Metastasectomy
01/2022
1
Conservative Treatment
10/2021
1
Patient-Controlled Analgesia (Analgesia, Patient Controlled)
08/2019
1
Analgesia
08/2019
1
Operative Surgical Procedures
01/2019
1
Cardiopulmonary Bypass (Heart-Lung Bypass)
08/2015
1
Immunotherapy
10/2013
1
Kidney Transplantation
03/2013
1
Combined Modality Therapy
12/2012
1
Blood Transfusion (Blood Transfusions)
12/2009